Results Anti-Q10 CTL Recognize H-2K". H-2K6'"1 is a mutant gene derived from H-Mb. The mutation involves changes in 7 by that encode amino acid residues 152, 155, and 156. It has been suggested that this mutant may be the result of a gene conversion event between Q& and H-Mb since the former gene shares H-2K" nucleotides in the region where the mutation occurred (14, (34) (35) (36) . Q10 is a secreted class I molecule and cannot be tested directly as a target for CTL (36) (37) (38) . However, by shuffling the first three exons of Q10d with the latter five exons of H-2L", a hybrid molecule can be expressed on the cell membrane of transfected L cells containing the al and a2 domains of Q10 together with the carboxy-end of the molecule derived from H-2Ld (31) . We recently showed CTL activity can be generated against this molecule and it is specific for determinants controlled by the al and a2 and not the H-2Ld-encoded 0 domain (29, 30) . Since Q10 shares the H-2Kbm 1 mutant amino acids at positions 152, 155, and 156 (see Table III ), we tested whether anti-Q10 CTL would crossreact on H-2Kbm', Anti-Q10 CTL were generated by stimulating spleen cells from (C3H x B6.K1)F1 (K''D'F/KbDb) mice with L cells (H-2k) expressing the Q10d/L d hybrid molecule . The resulting CTL were tested for reactivity against Q10d/Ld-transfected L cells, H-2Kb'"' lymphoblasts, or target cells derived from a panel of H-2K b mutant strains including H-2Kbm3, 5, 6, 8, 10, 11 . These other mutant strains have amino acid substitutions in the H-2Kb molecule at sites that differ from H-2K bml (9, 10) . The data in Fig. 1 (left pano show that anti-Q10 CTL mediate specific lysis against Q10-transfected L cells with only weak lysis of L cells transfected with the tk gene, as previously described (29, 30) . The same effector cells also display strong lytic activity against H-2Kbm' targets, while little or no reactivity is detected on any of the other H-2Kb mutants ( Fig. 1 , right pano. Thus, anti-Q10-specific CTL crossreact on the H-2K" molecule that shares an alanine and two tyrosines at amino acid positions 152, 155, and 156, respectively, with Q10 (see Table III ). Anti-Q10 CTL crossreact on H-2K6" . (C3H x B6 .K1)F1 mice were primed in vivo with Q10d/Ld L cells followed by restimulation with the same cells in vitro. Specific release of 51 Cr from tk and Q10d/Ld transfected L cells left panno or H-2Kbm1,s,5,6,e,1 ,11 Con A lymphoblasts (right panel) is indicated. Note that H-2Kbme,1o,11 targets had the same level of lysis and thus are denoted by the same symbol. B6 Anti-H-2K" CTL Crossreact with QIVILd and H-2Ld. The above data demonstrate antigenic crossreactivity between Q10d and H-2Kbm 1 . In addition, crossreactivity between H-2Kbm1 and a D end-encoded molecule from the H-2d haplotype has been observed (39) . It has also been noted that the H-2Ld molecule has the same sequence as H-2Kbm 1 at the mutant amino acid positions 152, 155, and 156 and evidence has been provided that anti-H-2Ld CTL crossreact on H-2K bml (40, 41) . We previously showed that anti-H-2Ld CTL crossreact on Q10d (29). Thus, anti-H-2Ld CTL appear to have a subset of cells capable of recognizing both H-2Kbm1 and Q10d. The reactivity of B6 anti-H-2Kbm 1 CTL on H-2Ld targets has been examined using a monolayer absorption technique and two subpopulations of CTL were detected directed at H-2d targets (19) . One apparently recognized H-2Ld while the second recognized another H-2 d-encoded molecule, possibly H-2Kd .
Based on the above studies, we reasoned that B6 anti-H-2K bm1 CTL would crossreact on Q10d and thus tested these effector cells for reactivity on H-W, H-2Kb"'', H-2Ld, and Q10d/Ld L cells . B6 anti-H-2k bm1 CTL specifically lyse H-2K bm1 L cells (Fig. 2) . In addition, a lesser amount of lysis was noted on both H-2Ld-and QlOd/Ld-expressing targets. This weaker lysis is consistent with a subset of the B6 anti-H-2K bmt CTL population being crossreactive . Thus, within the repertoire of B6 anti-H-2Kbm 1 CTL there exist populations that recognize H-2Ld , Q10d/L d, and another H-2d-encoded MHC molecule, possibly H-2Kd.
Anti-Q10 CTL Recognition ofH-2K" is Affected by Mutations at Both Positions 152 and 155-156. Since the H-2Kbm1 mutation is a complex event involving three amino acid substitutions, it is not possible to distinguish which of these changes controls the immunodominant epitope recognized by anti-Q10 CTL . To address this, anti-Q10 CTL were tested for their ability to recognize H-2K bm1 molecules in which amino acid position 152 or 155 and 156 were changed back to the wild-type H-2Kb residue by site-directed mutagenesis . The data in Fig. 3 of the H-2Kb residue glutamic acid rather than alanine at position 152 eliminates recognition of H -2Kb-I by anti-Q10d CTL. Similarly, the presence of H-2Kb residues arginine and leucine rather than tyrosines at positions 155 and 156 also results in a loss of recognition. It should be noted that both revertant cell lines express equivalent amounts of antigen as that of H-2Kb-and H-2Kbm 1 -expressing L cell lines, as determined by RIA (32) and cytofluorimetry (data not shown) . In addition, both revertant cell lines are lysed by B6 anti-H-2Kb-1 CTL (32) . The background lysis seen on H-2Kb is a phenomenon observed by us and other investigators 50 and is especially noted when effector cells are taken from animals previously primed in vivo with L cell transfectants (29, 30, 42) . This lytic activity is not specific for H-2Kb since equivalent lysis is also detected on L cells tmnsfected with the tk gene only (data not shown) . Thus, the recognition of H -2Kbm1 by anti-Q10 CTL requires the mutant amino acids at both positions 152 and 155-156 .
Animals Tolerant to H-2K6" do not Generate anti-Q10 CTL that Crossreact on H-2d Antigens. The previous data indicate that anti-Q10 CTL crossreact on H-2Kbml . We have previously shown that these CTL recognize H-2Kd, H-2Ld, and a third H-2"-encoded molecule controlled by a gene mapping between H-2D' and H-2V (30) . To further establish the existence of a common epitope in multiple class I alloantigens recognized by anti-Q10 CTL, CTL were generated using responder spleen cells from (C3H x H-2Kbm 1 )F l mice. We reasoned that only a portion of the anti-Q10 CTL response would be directed at the common epitope controlled by the amino acids at positions 152, 155, and 156 . Thus, by removing the subset of CTL reactive against this epitope (by using mice expected to be tolerant to this determinant), a loss of crossreactivity against other molecules containing the postulated common epitope should occur. The data in Fig . 4 show that (C3H x H-2Kbm 1 )F l mice generate anti-Q10-specific CTL activity, as evidenced by lysis of Q10d/Ld L cell targets (left panes . However, reactivity on H-2Kd-expressing B10 .D2(R103) (K"D') and H-2Ld -expressing B10.A(3R) (KIDdL~target cells does not occur (right paneo . In addition, H-2Kbm1 targets are not lysed (data not shown). Thus, tolerance to H-2Kbm1 results in a loss of reactivity to the other H-2d-encoded crossreactive antigens .
In a reciprocal fashion, anti-Q10 CTL were generated using spleen cells from (C3H x BALB/c)Fi responders. The data in Fig. 5 show these mice capable of generating an anti-Q10-specific response by killing Q10d/Ld L cell targets (left panes. However, reactivity on H-2K11 target cells is greatly reduced (right paneo . Thus, these data support the postulate that H-2 d molecules, H-2Kbm 1 , and Q10d share a common epitope defined in part by amino acids 152, 155, and 156 . We further tested whether (C3H x BALB/c-H-2dm 2 )Ft mice could generate anti-Q10 CTL that crossreact on H-2Ld and H-2Kbmt . While BALB/c-H-2dm 2 (KdDm ice have deleted the H-2V gene (43), they do express H-2K' that shares tyrosines at positions 155 and 156 with Q10 . The data in Fig. 6 indicate that cells from these mice generate strong lytic activity on H-2Kbmt_ and H-20-expressing B10.A(3R) targets (right panel). Since H-2Kd differs from H-2Ld and H-2Kbmt at position 152 in that H-2K1 encodes an aspartic acid rather than an alanine, this suggests that this residue has a significant effect on the recognition of the crossreactive epitope . However, it should also be noted that all three of these molecules have other amino acid differences, particularly in the al domain, as will be discussed later.
Specificity ofAnti-Ql Ut CTL Clones. Although the data presented indicate that the presence of certain amino acids at positions 152, 155, and 156 coincides with Q10 crossreactivity, it is not clear whether the same CTL receptor interacts with each alloantigen. Thus, it is possible that different CTL subsets are involved in the recognition of each molecule. To resolve this, anti-Q10d bulk CTL cultures were cloned by limiting dilution on H-2Kb-1 or BALB/c feeder cells. This approach was necessary since attempts to clone and maintain long-term lines using L cell stimulators were unsuccessful.
The lytic activity of the clones generated were tested on a panel of target cells and grouped into four patterns of reactivity. The data in Fig . 7 indicate that group I clones show significant lysis of H-2K'mi and Q10d/Ld-transfected L cells, but only marginal recognition of H-2Ld. Group II clones exhibit reactivity on H-20 and Q10'/L', but do not lyse H-2Kbmt targets. Group III clones exhibit reactivity on H-2Kbm1-, H-2Ld-, and Q10d/Ld-expressing targets . Ofparticular interest is the reactivity ofgroup IV clones. These clones have strong reactivity on L cells expressing H-2Kbmt, H-2Ld, or Q10d/L d molecules, and weak reactivity on H-2Dd. In addition, they recognize H-2Kd since they lyse B10 .D2(R103) (Kd/DI) but not B10 (K'ID') Con A lymphoblasts (data not shown) . Thus, this group of clones has a specificity closest to that observed in the bulk population, although it does display weak reactivity towards H-2Dd. The reactivity patterns of the anti-Q10 clones are summarized in Table I . It was also noted that group I, III, and IV clones do not react on the H-Mb-I revertant molecules Glu(152) and Arg-Leu(155-156), as expected (data not shown) . While these data demonstrates that individual anti-Q10 CTL clones crossreact on multiple class I molecules, many ofthe clones do not recognize all of the antigens carrying the Q10 sequence at positions 152, 155, and 156 ; e.g., note that group I clones do not react on H-2L'. Thus, these data suggest that other amino acids in class I molecules influence recognition.
Changes in the Sequence ofthe al Helix between Positions 63 and 73 ofH-2Ld Affects Recognition by anti-Q10 CTL Clones. The data thus far describe a CTL epitope controlled by amino acids 152, 155, and 156 in the a2 domain. This epitope can be recognized by bulk and cloned anti-Q10 CTL and is present in multiple class I Reactivity Patterns of Anti-Q10 CTL Clones +, Strong reactivity ; -, no reactivity. R103 and B10 columns represent reactivity on B10 .D2(R103) and BIO Con A lymphoblast targets. The Kb"', Glu(152), Arg-Leu(155-6), Ld, QI0, M66, M70, M73, Dd, and Ltk columns represent reactivity on L cells transfected with the H-2Kb", Glu(152), Arg-Leu(155-6), H-2Ld, QIO d/Ld, M66, M70, M73, H-2Dd, and HSVik genes, respectively . Note that each group represents multiple clones exhibiting the same reactivity pattern . Na, not applicable . molecules; i.e., H-2K bmt, H-2L d, H-2Kd, and Q10d/Ld . Recently, we reported the influence of amino acids in the a1 domain of H-2Dd (from positions 63-73) in controlling CTL epitopes recognized by anti-H-2Dd CTL (33) . Site-directed mutagenesis was used to introduce H-2Dd-specific codons into the second exon (encoding the a1 domain) of H-2L d. L cell lines transfected with these mutant H-2Ld genes were used in this study to assess the contribution of the a1 domain in the recognition of H-2Ld by anti-Q10 CTL.
The panel of anti-Q10 CTL clones were tested for their ability to recognize three independent H-2Ld mutant molecules. M66 acquired H-2Dd amino acids at positions 63, 65, and 66 ; M70 acquired an additional H-2D d amino acid at position 70; and M73 included H-2D'-specific changes at positions 63, 65, 66, 70, and 73 (Table II) . The effect of these various amino acid substitutions on the recognition of H-2Ld by anti-Q10 CTL correlates with the crossreactivity patterns of the various groups of anti-Q10 CTL clones . Thus, group I clones display marginal lysis of wild-type H-2Ld cells and no lysis of M66 or H-2Dd-expressing L cell targets (Fig. 8) . However, this group does crossreact on the mutants M70 and M73. H-2Kbm 1 , Q10d, and H-2Dd have identical amino acids at positions 63, 70, and 73, and at position 66, Q10d and H-2Dd have an arginine while H-2Kbmt has a lysine (Table II) . Thus, introducing changes into the H-2Ld molecule to produce M70 and M73 makes H-2Ld more homologous to H-2K" and Q10d and allows H-2Ld to gain the crossreactive epitope. CTL clones from groups II and III, which react on H-2Ld and Q10d/Ld, do not react on the M66 mutant cell line . However, they show strong reactivity on the M70 and M73 mutant cell lines. This suggests that the introduction of the changes at positions 63, 65, and 66 causes a loss of the H-2Ld (a2 domain-controlled) epitope that can be restored by an additional amino acid substitution at position 70 . The additional change at position 73 has no discernable effect . Group IV CTL clones, which crossreact on H-2Kbm 1, H-2L d, H-2Kd, and QIOd/Ld, show strong reactivity on M66, M70, and M73 cell lines. Thus, the recognition of H-2Ld by this group is not influenced by H-2Dd-specific amino acid substitutions in the al domain. These clones do, however, exhibit weak activity on H-2D 1, as previously noted. Taken together, these data show that while amino acids at posi- tions 152, 155, and 156 control the expression ofthe Q10 crossreactive epitope, other amino acids in the al helix also influence this determinant. Discussion We have shown that bulk-cultured CTL generated against the hybrid class I molecule Q10d/L d crossreact on H-2Kbm1, H-W, and H-W. This finding was confirmed by demonstrating that CTL clones derived from these bulk cultures displayed a similar specificity. Since H-2Kb m1 revertant molecules that have amino acids at positions 152 or 155 and 156 changed back to the wild-type H-2Kb residues are not recognized by these CTL, this reactivity coincides with the presence of an alanine or aspartic acid (in the case of H-2Kd) at position 152 and tyrosines at positions 155 and 156 in the a2 helical region in all four of these molecules. Support for the presence ofthis common epitope also comes from the demonstration both by us and others that anti-H-2K lbm1 CTL crossreact on H-2Ld, Q10d/Ld, and H-2Kd and the finding that anti-H-2Ld CTL recognize both Q10d/Ld and H-2Kbmt (19, 29, 40, 41) .
The three-dimensional structure of the human class I molecule HLA-A2 has been recently shown to have a surface consisting of two antiparallel a-helical regions overlaying eight R-pleated strands. It has been suggested that residues in the helices, together with particular amino acids on the strands, are involved in binding antigenic peptides and/or the TCR receptor (20, 21) . The a2 domain-encoded helix consists of amino acid residues 138-173, which includes positions 152, 155, and 156. Some of the CTL-defined HLA class I variants have amino acid substitutions in this region (16, 17) . HLA-A3 .2 varies from the HLA-A3 .1 molecule at positions 152 and 156 and the substitution at residue 152 has been shown to profoundly affect how these molecules are recognized by both alloreactive and MHC-restricted CTL (44) . Thus, in both mouse and man substitutions involving residues 152, 155, and 156 affect particular CTL epitopes. To further underscore the role of these amino acids in controlling CTL determinants, it should be noted that the H-2 class I molecules containing the Q10 crossreactive epitope vary considerably. For example, Q10 differs from H-2Kbm', H-2L d, and H-2Kd, by 26, 25, and 39%, respectively, of amino acids contained in the two helices and R strands. These amino acids represent residues that could potentially contact an antigenic peptide or TCR (21) (see Tables II and  III) . Further, approximately half of these differences represent amino acids with a variability index greater than six (45) (see Tables II and III) .
Polymorphic determinants recognized by alloreactive CTL have been mapped to the al and a2 external domains of class I molecules (22, 46, 47) . H-2 antigens consisting of al and a2 domains derived from different class I molecules have been created in an attempt to determine whether CTL determinants are linear structures in either a 1 or a2, or nonlinear dependent on amino acids from both domains. When this was studied using H-2Dd and H-2L d domain-shuffled molecules, it was noted that anti-H-213d and anti-H-W CTL recognized a construct consisting of Dd amino acids in the al and Ld amino acids in the a2 domain (26) . This finding suggests that H-2Dd-specific epitopes are primarily controlled by the al domain ; whereas H-2Ld epitopes, including the Q10 crossreactive epitope described here, are controlled primarily by amino acids in the a2 domain . This is supported by the finding that the reciprocal Ld/Dd domain-shuffled molecule was recognized by neither anti-H-213d or anti-H-2Ld CTL (27) . Recently, we further defined the importance of amino acid residues 63-73 in controlling H-2D d CTL epitopes by showing that changing amino acids in this region of the H-2L d molecule to the H-2Dd type allowed these mutant molecules to be recognized by anti-H-213d CTL (33) .
H-2Ld epitopes have also been localized to the a2 domain by demonstrating that anti-H-W CTL recognize the recombinant molecule H-2dm1 which contains Dd amino acids in the al and NH2-terminal end of the a2 domain and Ld amino acids in the COOH-terminal end of a2 (48, 49) . We have noted that anti-Q10 CTL have a similar reactivity against H-2dm1 (30) .
Since most other domain-shuffled class I molecules are not recognized by alloreactive CTL (22) (23) (24) (25) 27) , it is likely in the above-mentioned examples that al domain H-2d amino acids are permissive for the expression of H-2Ld a2 domain epitopes and vice versa. The data presented in this study not only support this possibility but identify specific amino acids in the al helix that control the expression of the Q10 crossreactive epitope. For example, although group I anti-Q10 clones marginally recognize H-2L d, they do react with H-2Ld mutant molecules that have H-2D d CTL epitopes may appear to be mapped solely to amino acids present in the al or a2 domain-encoded a helices, the data presented in this report demonstrate that a2 domain epitopes are dramatically affected by alteration of amino acids in the a1 domain .
Using computer-aided modeling, the spatial positioning of Q10 residues relative to HLA-A2 was found to be quite similar (P Bjorkman, personal communication). However, there is an effect on the size of the proposed antigen-binding cleft between the two helices in that the tyrosine residues at positions 155 and 156 in Q10 have significantly larger side chains than the glutamine and leucine residues present in the HLA-A2 molecule . Since these residues point down and into the cleft in both Q10 and HLA-A2, the tyrosines in Q10 reduce the size of the pocket in this region . Further, amino acids at positions 97 (tryptophan), 99 (tyrosine), 159 (tyrosine), and 167 (tryptophan) all have large side chains, and due to their orientation in the groove, also tend to reduce its size (see Table III ) . It is interesting to note that unlike H-2Kb, the H-2K bm1 molecule (which has tyrosines at positions 155 and 156) does not function as a restricting element for most antigens that have been tested (50-52). It is possible that H-2Kbml with a reduced groove size can no longer bind antigenic peptides, especially if they require an a-helical conformation, as previously suggested (53) (54) (55) . Alternatively, the size of the Q10 pocket may limit the number of peptides capable of binding to this class I molecule or allow for peptides to bind with a linear rather than a-helical configuration.
It has been proposed that alloreactive CTL may recognize class I molecules together with self peptides that occupy these pockets (21) . If the Q10 molecule has a smaller peptide binding cleft, then it is possible that a relatively large proportion of cell membrane Q10d/Ld molecules lack self peptides . This would tend to make CTL recognition of Q10 specific for amino acids on the two helices, directly. Thus, this may explain the strong influence of the residue at position 155, whose side chain is oriented in the presumed direction of the TCR, and residue 152, which should have a similar orientation on the a helix, in controlling the crossreactive epitope. Summary CTL derived from (C3H x B6 .K1)Fl animals were sensitized against L cells that express the transfected gene product Q10d/Ld . These CTL were highly crossreactive against three other class I molecules, H-2Kbm 1 , H-W, and H-2K' . In an attempt to define this crossreactive epitope it was noted that between 25 and 39% of amino acids in the a helices and central R strands of these three molecules vary from Q10d. These amino acids represent residues that have been proposed to potentially interact with a peptide antigen or TCR (21) . However, all four molecules share the amino acid tyrosine at positions 155 and 156. Additionally, Q10d, H-2Kb m1 , and H-2L d share alanine at position 152, while H-2Kd has an aspartic acid . We showed that these residues were important in controlling this epitope by the finding that anti-Q10 d CTL did not recognize H-2Kbm1 revertant molecules that had either the position 152 alanine changed back to the wild-type H-2Kb residue (glutamic acid) or position 155 and 156 tyrosines changed back to wild-type residues arginine and leucine . Further evidence that these molecules share a crossreactive epitope was noted by the failure of (C3H x H-2Kbmt)Fl animals to generate CTL that recognized H-2L' or H-2K, and the inability of(C3H x BALB/c)Fi animals to generate CTL reactive against H-2Kbmt . CTL from these mice were still able to recognize Q10d/Ld indicating that other epitopes could be detected if natural tolerance prevented recognition of the crossreactive epitope . To further define the epitope, CTL clones were generated against Q10 d/Ld and maintained on either H-2Kb" or BALB/c feeder cells . In addition to testing these clones on the target cells described above, mutant molecules derived from H -2Ld, which have amino acid substitutions in their al domain, were analyzed. It was noted that some anti-Q10 clones that did not crossreact on H-2Ld did react against H-2Ld mutant antigens that had H-213d amino acid substitutions in the al domain at positions 63, 65, 66, and 70. Other clones had differential reactivities on these H-2Ld mutants further substantiating that al domain amino acids play a role in controlling the expression of the crossreactive epitope .
Thus, four class I molecules with multiple amino acid differences in their a1 and a2 domains share a crossreactive epitope readily recognized by alloreactive CTL. This epitope is dependent on the presence of amino acids at positions 152, 155, and 156 in the a2 helix as well as amino acids between residues 63 and 73 in the al helix . The role ofthese residues in defining the nature ofthis alloreactive epitope is discussed .
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